RBS — Ramdevbaba Solvent Balance Sheet
0.000.00%
- IN₹2.07bn
- IN₹3.07bn
- IN₹6.98bn
Annual balance sheet for Ramdevbaba Solvent, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash | |||
Cash and Short Term Investments | 8.03 | 2.01 | 3.56 |
Net Total Accounts Receivable | |||
Net Total Receivables | 203 | 387 | 427 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 611 | 780 | 988 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 393 | 524 | 896 |
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 1,013 | 1,313 | 1,906 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 563 | 669 | 972 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Liabilities | 730 | 965 | 1,428 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 282 | 348 | 478 |
Total Liabilities & Shareholders' Equity | 1,013 | 1,313 | 1,906 |
Total Common Shares Outstanding |